MAMuhammet Arslan

Muhammet Arslan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Muhammet Arslan has a total of 267 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Superb microvascular imaging for evaluating the efficacy of microwave ablation in primary Hyperparathyroidism: A prospective study

    by Sercan Vurgun, Muhammet Arslan, Kadir Han Alver, Mahmut Demirci, Ayten Eraydın, Semin Melahat Fenkci


  • Silent but Severe: Transplant Renal Artery Stenosis Causing Acute Graft Dysfunction in a Child With Cystinosis

    by Tülay Becerir, Ümmühan Seda Altıntaş, İlknur Girişgen, Miraç Burak Kabukcuoğlu, Pınar Kılıç, Muhammet Arslan

    Background: Transplant renal artery stenosis (TRAS) is a potentially reversible vascular complication after kidney transplantation and an important cause of graft dysfunction in children. It usually presents with hypertension and/or impaired graft function but may occasionally remain clinically silent. Case Presentation: We report an 11‐year‐old girl with cystinosis who underwent living‐donor kidney transplantation outside our national, regulated transplant program and was referred to our center for follow‐up. Early post‐transplant Doppler ultrasonography was normal. At 10 weeks post‐transplant, she developed an asymptomatic but severe rise in serum creatinine without hypertension. Imaging revealed a short, focal stenosis at the arterial anastomosis. Percutaneous transluminal angioplasty was successfully performed, followed by short‐term anticoagulation and antiplatelet therapy, with rapid and sustained recovery of graft function. Conclusion: This case highlights that TRAS may present without hypertension and underscores the importance of careful surveillance, particularly in children transplanted outside regulated transplant programs.

  • Open Access

    Percutaneous endobiliary ablation (RFA and MWA) prior to stenting: assessing feasibility and outcomes in malignant biliary obstruction

    by Mahmut Demirci, Muhammet Arslan, Kadir Han Alver, Halil Serdar Aslan, Sercan Vurğun

    Purpose: This study aims to evaluate the feasibility and effectiveness of percutaneous endobiliary Microwave Ablation (MWA) and Radiofrequency Ablation (RFA) prior to metallic stent placement for managing symptomatic, unresectable malignant biliary obstructions (MBOs).Materials and methods: We conducted a retrospective cohort analysis of 122 patients diagnosed with malignant tumors causing biliary obstructions, comparing outcomes between those receiving stents only and those undergoing prior ablation. Data collected included patient demographics, procedural details, complication rates, stent patency, and overall survival.Results: Among the 122 patients, 101 received stents alone, while 21 underwent ablation (13 with MWA and 8 with RFA). There was no significant difference in stent patency duration (255.7 days for ablation vs. 219.6 days for stent-only, p=0.218) or overall survival (average of 123 days, p=0.105). The complication rate was significantly higher in the ablation group (p=0.023).Conclusion: While endobiliary ablative treatments before metallic stenting appear feasible for palliative care of unresectable MBOs, our findings indicate no significant improvement in stent patency or overall survival. Further randomized controlled studies are necessary to clarify the efficacy and necessity of these techniques.


  • Open Access

    Impact of biopsy route, muscle pathway, and cortex target on safety and diagnostic yield in ultrasound-guided renal parenchymal biopsy

    by Kadir Han Alver, Halil Serdar Aslan, Muhammet Arslan, Muhammed Tekinhatun, Mahmut Demirci, Nagihan Yalçın, Ahmet Baki Yağcı

    Impact of biopsy route, muscle pathway, and cortex target on safety and diagnostic yield in ultrasound-guided renal parenchymal biopsy - Diagnostic and Interventional Radiology


  • Open Access

    Sarcopenic Obesity and Sarcopenic Visceral Obesity, Calculated Using the Skeletal Muscle İndex and Visceral Fat İndex at the L3 Vertebra Level, Do Not Predict Survival Rates in Endometrial Cancer Patients

    by Melek Özdemir, Gamze Gököz Doğu, Burcu Yapar Taşköylü, Muhammet Arslan, Burak Kurnaz, Atike Gökçen Demiray, Arzu Yaren, Serkan Değirmencioğlu, Yeliz Arman Karakaya

    Objective: Obesity increases the risk of endometrial cancer (EC). In this study, we aimed to investigate the prognostic effect of sarcopenia, sarcopenic obesity and sarcopenic visceral obesity, calculated with the help of cross-sectional imaging methods of muscle and visceral adipose tissue from body composition parameters, in EC. Methods: Patients diagnosed with EC were identified between January 2014 and June 2024. The combination of radiological markers and patient outcomes can predict prognosis. The skeletal muscle index (SMI) and visceral fat index (VFI) were calculated from computed tomography (CT) and/or abdominal magnetic resonance (MR) scans taken at the time of diagnosis at the Lumbal 3 (L3) vertebra level. The findings of these analyses demonstrate the strongest correlation with the ratio of muscle and visceral fat tissue throughout the body. The loss of muscle and fat is an unfavourable indicator in patients with EC. The present study analysed the prognostic values of sarcopenia, sarcopenic obesity, sarcopenic visceral obesity, and the visceral fat index in EC. The total skeletal muscle area was calculated in square centimetres. Body surface area (m2) was calculated using the Mosteller formula: ((height (cm) × weight (kg))/3600)1/2. To normalize body composition components, the skeletal muscle index was calculated as cm2/m2. Results: The study comprised a total of 236 EC patients. The prevalence of sarcopenia, sarcopenic obesity, and sarcopenic visceral obesity were found to be 48.31%, 33.47%, and 22.88%, respectively. The presence of sarcopenia, high VFI levels, sarcopenic obesity, and sarcopenic visceral obesity did not demonstrate statistical significance in the survival analysis. However, stage increase (p = 0.001), primary tumour localization in the lower uterine segment (p = 0.001), serous carcinoma (p = 0.001), increased grade in endometrioid carcinoma (p = 0.023), and lymphovascular invasion (p = 0.001) were significantly associated with increased mortality risk. The presence of sarcopenia was found to be significant in patients with obesity (p = 0.008) and those aged ≥ 65 years (p = 0.001). Conclusions: In EC survival, established prognostic factors such as serous histopathology, LVI positivity, and the extent of surgical staging are prioritised. The presence of these well-established markers means the potential effect of BMI-based observations, such as the ‘obesity paradox’, and even body composition measurements, such as sarcopenic obesity, are now statistically insignificant. Our findings suggest that aggressive tumour biology (serous type, LVI) and surgery, rather than metabolic variables such as sarcopenia, sarcopenic obesity and sarcopenic visceral obesity, are the direct reason for the survival difference. This is due to the tumour’s aggressive nature and clinical characteristics (e.g., age at diagnosis, operability, stage, primary tumour localization in the lower uterine segment, serous carcinoma, grade, and LVI positivity) rather than metabolic variables.


  • Computed Tomography-guided Percutaneous Pelvic Bone Biopsy: Technical Success, Diagnostic Performance, and Safety

    by Kadir Han Alver, Muhammet Arslan

    Objective: To evaluate the technical success, diagnostic performance, and complications of CT-guided pelvic bone biopsies. Material and Method: Fifty patients (32 women, 18 men; mean age: 57.5 ± 15.5 years; range: 20–91) who underwent CT-guided pelvic bone biopsy (sacrum, ilium, ischium, pubis, proximal femur) between 2017 and 2024 were included. Biopsies were performed by interventional radiologists with a minimum of five years of experience. Lesion size, location, type (lytic, sclerotic, or mixed), pathology results, technical success, diagnostic performance, and complications were recorded from patient files and the Picture Archiving and Communication System (PACS). Complications were classified as minor or major according to the Society of Interventional Radiology (SIR) guidelines. Results: Technical success was 100% (50/50). Pathology revealed malignancy in 25 (50%) patients, benignity in 15 (30%), and nondiagnostic results in 10 (20%), yielding a diagnostic performance of 80%. Nondiagnostic lesions were significantly smaller than malignant (p=0.002) and benign (p

  • Open Access

    Predictive factors for spontaneous dislodgement of percutaneous nephrostomies for malignant ureteral obstruction

    by Ayşe Rüksan Ütebey, Halil Serdar Aslan, Muhammet Arslan, Kadir Han Alver, Hakkı Peker, Muhammed Tekinhatun, Ahmet Baki Yağcı, Nuran Sabir

    Purpose: To investigate the etiology of spontaneous percutaneous nephrostomy (PCN) catheter dislodgements and evaluate factors potentially associated with these dislodgements, including muscle-to-fat composition and tissue characteristics of catheter traces. Materials and methods: Data from 92 patients (63 males, 29 females; mean age 63.9 ± 11.4 years, range 28–88) undergoing 151 PCN catheter replacements between January 2016 and June 2021 were analyzed. Patients were divided into Group 1 (prophylactic replacements every 3 months, n = 41) and Group 2 (at least one spontaneous dislodgement, n = 51). Associations were evaluated for factors including intraabdominal visceral adipose tissue index (IAVATI), subcutaneous adipose tissue index (SATI), and abdominal perimeter. Other variables assessed were Eastern Cooperative Oncology Group (ECOG) performance status scores, psoas muscle index (PMI), renal size, renal parenchymal thickness, renal cortex-to-skin distance, posterolateral abdominal wall muscle thickness, and PCN replacement frequency. Results: No significant differences were identified between Group 1 and Group 2 in IAVATI, SATI, or abdominal perimeter values (p = 0.210–0.412). A significant difference in ECOG performance status scores (p = 0.0001), PMI (p = 0.04) and lower renal size, renal parenchymal thickness, renal cortex-to-skin distance, and posterolateral abdominal muscle thickness (p = 0.0001–0.039) were observed in Group 2. PCN replacements were significantly more frequent in Group 2 (p = 0.0001). Multivariate regression identified renal parenchymal thickness and abdominal wall muscle thickness as significant independent predictors (p = 0.0001, p = 0.02). ROC analysis yielded an AUC of 0.843 (95% CI: 0.769–0.917) for renal parenchymal thickness and 0.694 (95% CI: 0.610–0.778) for abdominal wall muscle thickness. Sensitivity and specificity rates were 73.1% and 96.4% for a 16 mm cutoff in renal parenchymal thickness, and 50.7% and 79.8% for an 8 mm cutoff in abdominal wall muscle thickness. Conclusion: A significant association was identified between spontaneous PCN catheter dislodgement and both the psoas muscle index and ECOG performance status scores, while no notable relationship was observed with abdominal visceral or subcutaneous fat tissue volumes or abdominal perimeter. The risk of dislodgement was found to increase with reduced renal parenchymal and abdominal wall muscle thickness, as well as with more frequent nephrostomy replacements, suggesting these parameters may serve as useful markers for identifying patients at higher risk. Graphical


  • Role of Superb Microvascular Imaging (SMI) vascularity index values and vascularity patterns in the differential diagnosis of malignant liver lesions

    by Halil Serdar Aslan, Muhammet Arslan, Kadir Han Alver, Sercan Vurgun, Mahmut Demirci, Muhammed Tekinhatun

    Purpose To evaluate the Superb Microvascular Imaging (SMI) vascular patterns and vascularity index (VI) values of malignant focal liver lesions (FLLs), assess their role in differential diagnosis, and examine interobserver agreement. Materials and methods A total of 107 patients (52 males, 55 females; mean age 62 ± 12.8 years, range 25–87) referred to the interventional radiology clinic for FLL biopsy between April 2022 and April 2023 were analyzed. Two radiologists independently assessed the SMI vascular patterns and calculated VI values. Differences among three lesion groups — hepatocellular carcinoma (HCC, n = 16), non-HCC primary liver malignancies (n = 16), and metastases (n = 75) — were evaluated, and interobserver agreement was assessed. Results Most metastases (88%) demonstrated hypovascular patterns, while HCCs predominantly exhibited hypervascular patterns (68.7–81.3%). Non-HCC primary malignancies showed no dominant vascular pattern. Significant differences in SMI patterns were observed among lesion types (p = 0.001–0.035). VI values for HCCs (7.53–7.73) were significantly higher than those for non-HCC malignancies (2.73–2.93) and metastases (1.35–1.36) (p = 0.0001). ROC analysis based on VI values yielded AUCs of 0.886–0.887, with a cutoff of 2.92 providing 81.3% sensitivity and 79.1–80.2% specificity for HCC diagnosis. The inter-reader agreement for SMI patterns had a kappa score of 0.634, while the intraclass correlation coefficient (ICC) for VI values was 0.959. Conclusion HCCs displayed more hypervascular SMI patterns and significantly higher VI values compared to other malignant FLLs, emphasizing the diagnostic potential of VI in distinguishing HCC from non-HCC tumors. Although metastases primarily exhibited hypovascular patterns and low VI values, no dominant vascular pattern was identified in non-HCC primary liver malignancies. Assessing VI values provided higher interobserver agreement compared to SMI patterns, enhancing objectivity and reproducibility.


  • Open Access

    Use of albumin and CRP related immuno-nutritional markers for prediction of locoregional response to treatment in unresectable hepatocellular carcinoma

    by Melek Özdemir, Gamze Gokoz Dogu, Burcu Yapar Taşköylü, Atike Gökçen Demiray, Serkan Değirmencioğlu, Arzu Yaren, Muhammet Arslan, Burçin Çakan Demirel, Tolga Doğan, Taliha Güçlü Kantar, et al.

    Objective:We analysed the relationship between albumin and CRP related inflammation markers (Controlling nutritional status(Conut)score, lymphocyte albumin factor(LA), albumin-bilirubin score (ALBI), highly sensitive modified Glasgow prognostic score (Hs-mGPS), Glasgow prognostic score(GPS)) and locoregional treatment response in HCC. Materials and methods:Among 180 HCC patients, 63 patients who underwent locoregional therapy were included in this study. Albumin and CRP related immuno-nutrition scores were calculated by recording routine laboratory tests between the fourth and eighth week after treatment. The predictive and prognostic value of these markers for overall survival(OS) and disease free survival after treatment(DFS) were analysed. Results:The mean age was 63 years (min-max:26-87) and 59 (93.7%) of the patients were male. The mean follow up period was 25 months and 53 patients were deceased (84.1%). mOS: 18.56 months (min-max: 13.13-23.99); mDFS: 7 months (min-max: 3.63-10.37) after locoregional treatment. Cut-off values of prognostic markers were determined by Roc analysis. Statistically significant correlation was found between age(p=0.019), Conut(p=0.001), GPS(p=0.028), Hs-mGPS(p=0.012), LA(p=0.017) and ALBI(p=0.002) and mOS. The relationship between Conut(p=0.002), GPS(p